MIBG Scan Market By Service provider (Hospitals, Private radiology clinics), By Application (Pheochromocytoma, Ganglioneuroma, Ganglioneuroblastoma, Paraganglioma, Carcinoid tumor, Neuroblastoma), Industry Trends, Estimation & Forecast, 2017 - 2025

Check Today's Best Price

$3500 Buy Now
MIBG Scan Market is expected to grow with a CAGR of XX% during the forecast period of 2018 to 2025.
  • Market Overview:

    MIBG scan, also called as MIBG scintigraphy or MIBG scintiscan, is a type of nuclear medicine procedure used to locate known or suspected neuroendocrine and neuroectodermal tumors. This scanning procedure injects a radioactive material called iodine-123-meta-iodobenzylguanidine (MIGB), the most sensitive and specific radioactive tracer used for the diagnosis and monitoring of neuroectodermal & neuroendocrine tumors. According to the American Cancer Society, neuroblastoma is the most prevalent cancer in infants of age less than one year. In addition, every year approximately 800 new cases of neuroblastoma arise in the United States, which is boosting the growth of global MIBG scan market. MIGB scan cannot be performed after the consumption of certain drugs such as opioids, amiodarone, reserpine, tricyclic antidepressants, sympathicomimetics, guanethidine, calcium channel blockers, & ACE inhibitors and requires prior discontinuation of these drugs before the administration of MIGB.

    In the current scenario, physicians are witnessing hurdles in the adoption of MIBG scan, especially in the paediatric neuroblastoma cases as it becomes difficult to extract the information from the low definition images produced with poor contours, resolution and contrast. However, technological advancements in the MIBG technology is expected to render lucrative opportunities to the market players active in the MIBG scan market during the upcoming years.

    The report provides detailed qualitative and quantitative analysis of the MIBG scan market. Market size and forecast in terms of value and volume has been provided for the period – (2018 – 2025) for the segments namely service provider and application in each of the major regions.

    MIBG Scan Market Segmentation

    By Service provider

    • Hospitals
    • Private radiology clinics

    By Application 

    • Pheochromocytoma
    • Ganglioneuroma
    • Ganglioneuroblastoma
    • Paraganglioma
    • Carcinoid tumor
    • Neuroblastoma
    • Others

    By Geography

    • North America
    o U.S.
    o Canada
    o Mexico

    • Europe
    o U.K.
    o France
    o Germany
    o Italy
    o Spain
    o Rest of Europe

    • Asia-Pacific
    o China
    o Japan
    o India
    o Korea
    o Rest of APAC

    • South America
    o Brazil
    o Rest of South America

    • Rest of the World
    o Middle East
    o Africa

    keyboard_arrow_up
  • CHAPTER 1. INTRODUCTION
    1.1. RESEARCH METHODOLOGY
    1.1.1. ERC DESK RESEARCH
    1.1.2. ERC DATA SYNTHESIS
    1.1.3. DATA VALIDATION AND MARKET FEEDBACK
    1.1.4. ERC DATA SOURCES
    CHAPTER 2. MIBG SCAN MARKET OVERVIEW
    2.1. MIBG SCAN MARKET INTRODUCTION
    2.2. GLOBAL MIBG SCAN MARKET REVENUE AND GROWTH RATE, 2017-2025
    2.2.1. GLOBAL MIBG SCAN MARKET REVENUE (MILLION USD) AND GROWTH RATE (%), (2017-2025)
    CHAPTER 3. GLOBAL MIBG SCAN MARKET BY SERVICE PROVIDER, 2017-2025
    3.1. HOSPITALS
    3.2. PRIVATE RADIOLOGY CLINICS
    3.3. GLOBAL MIBG SCAN MARKET REVENUE BY SERVICE PROVIDER, 2017-2025
    3.3.1. GLOBAL MIBG SCAN MARKET REVENUE (MILLION USD) AND SHARE (%) BY SERVICE PROVIDER, 2017-2025
    3.3.2. HOSPITALS MARKET REVENUE AND GROWTH RATE, 2017-2025
    3.3.3. PRIVATE RADIOLOGY CLINICS MARKET REVENUE AND GROWTH RATE, 2017-2025
    CHAPTER 4. GLOBAL MIBG SCAN MARKET BY APPLICATION, 2017-2025
    4.1. PHEOCHROMOCYTOMA
    4.2. GANGLIONEUROMA
    4.3. GANGLIONEUROBLASTOMA
    4.4. GLOBAL MIBG SCAN MARKET REVENUE BY APPLICATION, 2017-2025
    4.4.1. GLOBAL MIBG SCAN MARKET REVENUE (MILLION USD) AND SHARE (%) BY APPLICATION, 2017-2025
    4.4.2. PHEOCHROMOCYTOMA MARKET REVENUE AND GROWTH RATE, 2017-2025
    4.4.3. GANGLIONEUROMA MARKET REVENUE AND GROWTH RATE, 2017-2025
    4.4.4. GANGLIONEUROBLASTOMA MARKET REVENUE AND GROWTH RATE, 2017-2025
    Note: Similar information coverage has been provided for other application segment.
    CHAPTER 5. GLOBAL MIBG SCAN MARKET BY REGION, 2017-2025
    5.1. NORTH AMERICA
    5.1.1. U.S.
    5.1.2. CANADA
    5.1.3. MEXICO
    5.2. EUROPE
    5.2.1. U.K.
    5.2.2. FRANCE
    5.2.3. GERMANY
    5.2.4. ITALY
    5.2.5. SPAIN
    5.2.6. REST OF EUROPE
    5.3. ASIA PACIFIC
    5.3.1. CHINA
    5.3.2. JAPAN
    5.3.3. INDIA
    5.3.4. KOREA
    5.3.5. REST OF APAC
    5.4. SOUTH AMERICA
    5.4.1. BRAZIL
    5.4.2. REST OF SOUTH AMERICA
    5.5. REST OF THE WORLD
    5.5.1. MIDDLE EAST
    5.5.2. AFRICA
    5.6. GLOBAL MIBG SCAN MARKET REVENUE BY REGION, 2017-2025
    5.6.1. GLOBAL MIBG SCAN MARKET REVENUE (MILLION USD) AND SHARE (%) BY REGION, 2017-2025
    5.6.2. NORTH AMERICA MARKET REVENUE AND GROWTH RATE, 2017-2025
    5.6.3. EUROPE MARKET REVENUE AND GROWTH RATE, 2017-2025
    5.6.4. ASIA PACIFIC MARKET REVENUE AND GROWTH RATE, 2017-2025
    5.6.5. SOUTH AMERICA MARKET REVENUE AND GROWTH RATE, 2017-2025
    5.6.6. REST OF THE WORLD MARKET REVENUE AND GROWTH RATE, 2017-2025
    CHAPTER 6. MARKET DETERMINANTS
    6.1. MARKET DRIVERS
    6.2. MARKET RESTRAINTS
    6.3. MARKET OPPORTUNITIES
    6.4. MARKET DETERMINANTS RADAR CHART
    CHAPTER 7. GLOBAL MIBG SCAN MARKET COMPETITION BY SERVICE PROVIDERS
    7.1. GLOBAL MIBG SCAN REVENUE AND SHARE BY SERVICE PROVIDERS (2017-2025)
    7.1.1. GLOBAL MIBG SCAN REVENUE (MILLION USD) AND SHARE (%) BY SERVICE PROVIDERS (2017-2025)
    7.2. MIBG SCAN MARKET COMPETITIVE SITUATION AND TRENDS
    7.2.1. MIBG SCAN MARKET SHARE (%) OF TOP 3 SERVICE PROVIDERS
    7.2.2. MIBG SCAN MARKET SHARE (%) OF TOP 5 SERVICE PROVIDERS
    CHAPTER 8. COMPANY PROFILES
    8.1. CAPITAL HEALTH
    8.1.1. BUSINESS OVERVIEW
    8.1.2. COMPANY BASIC INFORMATION
    8.1.3. MIBG SCAN PRODUCT DETAILS
    8.1.4. CAPITAL HEALTH MIBG SCAN REVENUE AND GROSS MARGIN
    8.2. GE HEALTHCARE
    8.2.1. BUSINESS OVERVIEW
    8.2.2. COMPANY BASIC INFORMATION
    8.2.3. MIBG SCAN PRODUCT DETAILS
    8.2.4. GE HEALTHCARE MIBG SCAN REVENUE AND GROSS MARGIN
    8.3. JUBILANT PHARMA. LLC
    8.3.1. BUSINESS OVERVIEW
    8.3.2. COMPANY BASIC INFORMATION
    8.3.3. MIBG SCAN PRODUCT DETAILS
    8.3.4. JUBILANT PHARMA. LLC MIBG SCAN REVENUE AND GROSS MARGIN
    8.4. SIEMENS HEALTHCARE
    8.4.1. BUSINESS OVERVIEW
    8.4.2. COMPANY BASIC INFORMATION
    8.4.3. MIBG SCAN PRODUCT DETAILS
    8.4.4. SIEMENS HEALTHCARE MIBG SCAN REVENUE AND GROSS MARGIN
    CHAPTER 9. MIBG SCAN MARKET VALUE CHAIN ANALYSIS
    9.1. MIBG SCAN INDUSTRIAL CHAIN ANALYSIS
    9.2. CONSUMER ANALYSIS
    9.2.1. CONSUMER 1
    9.2.2. CONSUMER 2
    9.2.3. CONSUMER 3
    9.2.4. CONSUMER 4

    keyboard_arrow_up
  • • Capital Health
    • GE Healthcare
    • Jubilant Pharma. LLC
    • Siemens Healthcare
    • Others

    keyboard_arrow_up


    • Keep your personal detail safe with us. Privacy Policy
      This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

What Information does this report contain?

• What was the market size of the MIBG Scan Market in 2017 and the expected market size by 2025, along with the growth rate?
• An in-depth analysis of the current impacting factors, opportunities and challenges/restraints in the market
• Which are the largest revenue generating products, services or regions and their comparative growth rate?
• Which technology is in trend and how would it evolve during the forecast period (2017 – 2025)?
• Which are the leading companies in the MIBG Scan Market and their competitive positioning basis their market share, product portfolio, strategic attempts and business focus?

CLIENTS